NCT04310826View on ClinicalTrials.gov

Dietary Magnesium in Preventing Low Blood Magnesium Levels in Patients With Ovarian Cancer Receiving Carboplatin Chemotherapy

NAActive, not recruitingINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 23, 2019

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2026

Conditions
Ovarian Carcinoma
Interventions
DIETARY_SUPPLEMENT

Dietary Intervention

Receive dietary magnesium intervention

OTHER

Media Intervention

Undergo video interviews

BEHAVIORAL

Telephone-Based Intervention

Receive phone calls

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER